Gaucher disease is a rare genetic disorder in which a person lacks an enzyme called glucocerebrosidase.
Alternative NamesGlucocerebrosidase deficiency; Glucosylceramidase deficiency
Causes, incidence, and risk factorsGaucher disease affects an estimated 1 in 50,000 to 1 in 100,000 people in the general population. Persons of Eastern and Central European (Ashkenazi) Jewish heritage are at highest risk for the disease.
It is an autosomal recessive disease. This means that the mother and father must both pass one abnormal copy of the gene to the child in order for the child to develop the disease. A parent who silently carries an abnormal copy of the gene is called a carrier.
The lack of the glucocerebrosidase enzyme causes harmful substances to build up in the liver, spleen, bones, and bone marrow. The substances prevent cells and organs from working properly.
There are three main subtypes of Gaucher disease:
Symptoms vary depending on the type of disease, but may include:
The doctor will perform a physical exam. The patient may have signs of liver and spleen swelling, bone changes, lung disease, eye movement problems, heart problems, or hearing loss.
The following tests may be performed:
Enzyme replacement therapy is available. A bone marrow transplant may be needed in severe cases.
Support GroupsFor more information contact:
How well a person does depends on the subtype of the disease. The infantile form of Gaucher disease may lead to early death. Most affected children die before age 5.
Adults with the type 1 form of the disease can expect normal life expectancy with enzyme replacement therapy.
ComplicationsGenetic counseling is recommended for prospective parents with a family history of Gaucher disease. Testing can determine if parents carry the gene that could pass on the Gaucher disease. A prenatal test can also tell if the fetus has Gaucher syndrome.
ReferencesStanley CA, Bennett MJ. Defects of metabolism in lipids. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 86.
Kumar V, Abbas AK, Fausto N. Robbins and Cotran Pathologic Basis of Disease. 7th ed. St. Louis, Mo: WB Saunders; 2005:163-165.
Sidransky E, Lamarca ME, Ginns EI. Therapy for Gaucher disease: Don't stop thinking about tomorrow. Mol Genet Metab. 2007 Feb;90(2):122-5. Epub 2006 Nov 3.
Gaucher's Disease is Familial Splenic Anemia.
Symptoms of Gaucher disease can start in infancy, childhood, or adulthood.
Gaucher's disease is located on chromosome 1, which is not the sex chromosome, so no. It is not a sex linked disease.
The symptoms of Gaucher disease can be stopped and even reversed by treatment with injections of enzyme replacements.
Gaucher disease is the most common lysosomal storage disease. It was named for the French physician Phillipe Gaucher who first described it in 1882. The disease is caused by a lack of glucocerebrosidase, which causes a buildup of glucocerebroside in the tissues.
Three types of Gaucher disease have been identified, but there are many variations in how symptoms develop.
Gaucher disease
This disease affects males and females. 1 of 100 people in the United States are carries of the most common type of Gaucher disease
Carol Kari has written: 'Understanding Gaucher disease' -- subject(s): Gaucher's disease, Genetic aspects, Genetic aspects of Gaucher's disease, Inborn errors of Metabolism, Metabolism, Inborn errors of, Treatment
Gaucher disease is caused by a genetic defect in an enzyme called glucocerebroside. There are four different types of this disease. For more information about Gaucher disease visit Answers.com
Genetic counseling is advised for individuals with Gaucher disease and for their relatives to accurately assess risk and discuss testing options. For couples who previously had a child with Gaucher or in situations where both parents are.
Tay-Sachs was named after Wamen Tay and Bernard Sachs Correction: Tay-Sachs was named after Warren Tay and Bernard Sachs